June 28, 2002
Roche Laboratories Has Recalled Tamiflu Capsules
Nutley, NJ (SafetyAlerts)
- The Food and Drug Administration said that Roche Laboratories has recalled
Tamiflu Capsules (oseltamivir phosphate).
Tamiflu Capsules (oseltamivir phosphate),75mg, 10 capsule cartons and 15 x1
capsule Professional Samples, Rx only. Recall # D-336-2.
Cartons of 10 Capsules
B1022-01, exp. 6/02
B1023-01, exp. 6/02
B1024-01, exp. 6/02
B1025-01, exp. 6/02
B1029, exp. 9/02
B1029-01, exp. 9/02
B1025-02, exp. 6/02
Physician Samples (15s)
B1025-03, exp. 6/02.
Recalling Firm: Roche Laboratories, Nutley, NJ, by letter on April 19, 2002.
Manufacturer: F. Hoffmann - La Roche, AG CH-4070 Basel, Switzerland.
Firm initiated recall is ongoing.
Potential cross contamination with active ingredients which could include
mefloquine, levodopa/benserazide, and/or sulfamethoxazole.
VOLUME OF PRODUCT IN COMMERCE
1,021,141 trade lots; 1,800 free goods; 153,264 physician samples.